Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Ultrasound Evaluation

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

2Total
Not Applicable (1)
Phase 3 (1)

Trial Status

Completed1
Recruiting1
Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Research Network

Common Treatments

  • Ultrasound Evaluation1
  • Normobaric Hypoxia1
  • Acetazolamide1

Active Sponsors

  • National Center of Cardiology and Internal Medicine, Kyrgyz Republic1
  • Mona Lichtblau1
  • University of Zurich1
  • Peking Union Medical College Hospital1

Top Investigators

Related Conditions

  • Altitude Sickness1
  • Right Cardiogenic Pulmonary Edema1
  • Volume Status1
  • Hypoxia1
  • Glasgow Outcome Scale Extended1

Activity Timeline